Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells
- 1 June 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 223 (1) , 67-76
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma linesHead & Neck, 2003
- 5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 2003
- Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinomaInternational Journal of Clinical Oncology, 2003
- Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinomaCancer Letters, 2003
- Transfection of mutant p53 gene depresses X-ray- or CDDP-induced apoptosis in a human squamous cell carcinoma of the head and neckApoptosis, 2002
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001
- Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomasCancer Letters, 2000
- A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damageNature, 2000
- High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicinCancer, 1999
- p53 Mutations in Human CancersScience, 1991